查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513694

腦積水分流器市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2032

Hydrocephalus Shunts Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 344 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發佈了一份關於全球腦積水分流器市場的綜合報告。該報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

關鍵見解

  • 腦積水分流器市場規模（2024 年）：3.1549 億美元
  • 市場預測金額（2032 年）：4.155 億美元
  • 全球市場成長率（2024-2032 年複合年增長率）：3.5%

腦積水流市場：研究範圍

腦積水流術在腦積水的治療中發揮重要作用，腦積水的特徵是腦脊髓液在大腦中過度積聚。腦積水分流術透過促進腦室內多餘腦脊髓液的引流來緩解顱內壓並防止神經損傷。市場主要提供各種類型的分流器，如腦室腹腔分流器（VP）、腦室腹腔分流器（VPL）和腰腹腔分流器（LP），主要供醫院、神經科診所和專科手術中心使用。

推動市場成長的因素：

全球腦積水流量市場受到多種因素的推動，例如所有年齡層腦積水盛行率的增加、分流技術的進步以提高治療效果和患者的預後，以及全球醫療保健支出的增加。此外，人們對神經外科幹預措施認識的提高和診斷能力的提高也有助於市場擴張。

市場限制因素：

儘管成長前景廣闊，但腦積水分流市場面臨與分流併發症相關的課題，如感染、閉塞和機械故障，這些併發症需要進行手術修復，並影響患者的預後。一些地區也存在監管障礙和報銷限制，為市場進入和擴張造成障礙。

市場機會：

由於分流設計的技術創新、新興國家醫療基礎設施的增加以及微創手術技術的採用增加，腦積水分流市場正在經歷巨大的成長機會。醫療設備製造商、醫療保健提供者和研究機構之間的策略合作對於開發和銷售下一代分流系統至關重要。

本報告解決的關鍵問題

  • 推動腦積水流器市場全球成長的關鍵因素是什麼？
  • 哪些類型的分流器和技術在各種醫療機構中越來越受歡迎？
  • 分流材料與設計的進步如何改變競爭格局？
  • 誰是腦積水流動器市場的主要參與者？ 他們保持市場領先地位的策略是什麼？
  • 全球腦積水流動市場的新趨勢和未來前景是什麼？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第三章市場背景

  • 市場動態
  • 情境預測
  • 機會圖分析
  • 投資可行性矩陣
  • PESTLE 和 Porter 分析
  • 監理狀況
  • 依地區劃分的母公司市場前景

第四章全球腦積水流器市場分析

  • 2019-2023 年過去的市場規模金額（百萬美元）分析
  • 2024-2032 年當前及未來市場規模預測（百萬美元）
    • 年成長趨勢分析
    • 絕對數量機會分析

第 5 章全球腦積水流器市場分析：依產品

  • 簡介/主要發現
  • 2019-2023 年依產品劃分的歷史市場規模金額（百萬美元）分析
  • 2024-2032 年依產品劃分的當前和未來市場規模價值（百萬美元）分析和預測
    • 腦積水瓣膜
    • 腦積水導管
    • 神經導航系統
    • 其他
  • 年成長趨勢分析：依產品分類，2019-2023 年
  • 絕對價值機會分析：依產品分類，2024-2032 年

第 6 章全球腦積水分流器市場分析：依類型

  • 簡介/主要發現
  • 2019-2023 年依類型劃分的歷史市場規模金額（百萬美元）分析
  • 2024-2032 年當前和未來市場規模價值（百萬美元）分析和預測（依類型）
    • 心室 - 腹膜
    • 心室 - 心房
    • 心室 - 胸膜
  • 年成長趨勢分析：依類型劃分，2019-2023 年
  • 絕對機會分析：依類型劃分，2024-2032 年

第 7 章全球腦積水流器市場分析：依年齡層

  • 簡介/主要發現
  • 2019-2023 年依年齡組別劃分的歷史市場規模分析（百萬美元）
  • 2024-2032 年依年齡組別劃分的當前和未來市場規模價值（百萬美元）的分析和預測
    • 兒童
    • 成人
  • 年成長趨勢分析：依年齡組別劃分，2019-2023 年
  • 絕對機會分析：依年齡組別劃分，2024-2032 年

第 8 章全球腦積水流器市場分析：依最終使用者劃分

  • 簡介/主要發現
  • 2019-2023 年最終用戶歷史市場規模金額（百萬美元）分析
  • 2024-2032 年最終用戶當前和未來市場規模價值（百萬美元）分析和預測
    • 醫院
    • 門診手術中心
    • 其他
  • 年成長趨勢分析：依最終用戶劃分，2019-2023 年
  • 絕對價值機會分析：依最終使用者劃分，2024-2032 年

第 9 章全球腦積水流量器市場分析：依地區

  • 簡介
  • 2019-2023 年依地區歷史市場規模分析（百萬美元）
  • 2024-2032 年依地區劃分的當前市場規模價值（百萬美元）分析與預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 區域市場吸引力分析

第 10 章北美腦積水分流器市場分析（依國家）

第 11 章拉丁美洲腦積水分流器市場分析（依國家）

第十二章歐洲腦積水分流器市場分析（依國家）

第十三章亞太地區腦積水分流器市場分析（依國家）

第 14 章中東和非洲腦積水分流器市場分析（依國家/地區）

第十五章主要全國腦積水流器市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 中國
  • 日本
  • 韓國
  • 新加坡
  • 泰國
  • 印尼
  • 澳大利亞
  • 紐西蘭
  • 海灣合作委員會國家
  • 南非
  • 以色列

第十六章市場結構分析

  • 競爭對手儀表板
  • 競爭基準
  • 主要公司市佔率分析

第十七章競爭分析

  • 衝突詳情
    • B. Braun Melsungen AG
    • Sophysa
    • HpBio Proteses Inc.
    • Integra LifeSciences Holdings Corporation
    • KANEKA MEDIX CORPORATION
    • Medtronic
    • Natus Medical Incorporated
    • Spiegelberg GmbH &Co. KG
    • Desu Medical
    • Natus Neuro

第 18 章先決條件與使用的縮寫

第十九章研究方法

簡介目錄
Product Code: PMRREP33225

Persistence Market Research has recently released a comprehensive report on the worldwide market for hydrocephalus shunts. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Hydrocephalus Shunts Market Size (2024E): USD 315.49 million
  • Projected Market Value (2032F): USD 415.50 million
  • Global Market Growth Rate (CAGR 2024 to 2032): 3.5%

Hydrocephalus Shunts Market - Report Scope:

Hydrocephalus shunts play a critical role in the management of hydrocephalus, a condition characterized by excessive accumulation of cerebrospinal fluid within the brain. These shunts facilitate the diversion of excess fluid from the brain's ventricles to another part of the body, thereby alleviating intracranial pressure and preventing neurological damage. The market caters primarily to hospitals, neurology clinics, and specialized surgical centers, offering a variety of shunt types, including ventriculoperitoneal (VP), ventriculopleural (VPL), and lumboperitoneal (LP) shunts.

Market Growth Drivers:

The global hydrocephalus shunts market is driven by several key factors, including increasing prevalence of hydrocephalus across all age groups, advancements in shunt technology enhancing treatment efficacy and patient outcomes, and rising healthcare expenditures globally. Moreover, growing awareness about neurosurgical interventions and improved diagnostic capabilities contribute to market expansion.

Market Restraints:

Despite promising growth prospects, the hydrocephalus shunts market faces challenges related to shunt complications such as infection, blockage, and mechanical failure, which necessitate surgical revisions and impact patient outcomes. Additionally, regulatory hurdles and reimbursement limitations in some regions pose barriers to market entry and expansion.

Market Opportunities:

The hydrocephalus shunts market presents significant growth opportunities driven by technological innovations in shunt design, increasing healthcare infrastructure in emerging economies, and rising adoption of minimally invasive surgical techniques. Strategic collaborations between medical device manufacturers, healthcare providers, and research institutions are crucial for developing next-generation shunt systems and expanding market reach.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the hydrocephalus shunts market globally?
  • Which shunt types and technologies are gaining traction in different healthcare settings?
  • How are advancements in shunt materials and designs reshaping the competitive landscape?
  • Who are the key players contributing to the hydrocephalus shunts market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global hydrocephalus shunts market?

Competitive Intelligence and Business Strategy:

Leading players in the global hydrocephalus shunts market, including Ophysa,KANEKA MEDIX CORP.,Desu Medical, focus on innovation, product differentiation, and strategic alliances to strengthen their market position. These companies invest significantly in research and development to enhance shunt performance, minimize complications, and improve patient quality of life. Collaborations with healthcare providers and advocacy groups support market expansion efforts and promote clinical best practices.

Key Companies Profiled:

  • B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG),
  • Ophysa
  • HpBio Proteses, inc.
  • Integra LifeSciences Holdings Corporation
  • KANEKA MEDIX CORP.
  • Medtronic Plc
  • Natus Medical Incorporated
  • Spiegelberg GmbH & Co. KG
  • Desu Medical

Key Segments Covered in the Hydrocephalus Shunts Industry Report

Hydrocephalus Shunts Industry by Type

  • Ventriculo-Peritoneal
  • Ventriculo-Atrial
  • Ventriculo-Pleural
  • Lumbo-Peritoneal

Hydrocephalus Shunts Industry by Product

  • Hydrocephalus Valves
  • Hydrocephalus Catheters
  • Neuronavigation Systems

Hydrocephalus Shunts Industry by Age Group

  • Paediatric
  • Adults

Hydrocephalus Shunts Industry by End User

  • Hospitals
  • Ambulatory Surgical Centers

Hydrocephalus Shunts Industry by Region

  • North America Market
  • Europe Market
  • Asia-Pacific Market
  • Middle East & Africa Market
  • South America Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Hydrocephalus Valves
      • 5.3.1.1. Adjustable Pressure Valves
      • 5.3.1.2. Fix Pressure Valves
    • 5.3.2. Hydrocephalus Catheters
    • 5.3.3. Neuronavigation Systems
    • 5.3.4. Others
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2024-2032
    • 6.3.1. Ventriculo - Peritoneal
    • 6.3.2. Ventriculo - Atrial
    • 6.3.3. Ventriculo - Pleural
  • 6.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Type, 2024-2032

7. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Age Group

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Age Group , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Age Group , 2024-2032
    • 7.3.1. Pediatric
    • 7.3.2. Adults
  • 7.4. Y-o-Y Growth Trend Analysis By Age Group , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Age Group , 2024-2032

8. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2024-2032
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others
  • 8.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By End User, 2024-2032

9. Global Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Type
    • 10.2.4. By Age Group
    • 10.2.5. By End User
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Type
    • 10.3.4. By Age Group
    • 10.3.5. By End User
  • 10.4. Key Takeaways

11. Latin America Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Type
    • 11.2.4. By Age Group
    • 11.2.5. By End User
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Type
    • 11.3.4. By Age Group
    • 11.3.5. By End User
  • 11.4. Key Takeaways

12. Europe Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Type
    • 12.2.4. By Age Group
    • 12.2.5. By End User
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Type
    • 12.3.4. By Age Group
    • 12.3.5. By End User
  • 12.4. Key Takeaways

13. Asia Pacific Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. China
      • 13.2.1.2. Japan
      • 13.2.1.3. South Korea
      • 13.2.1.4. Singapore
      • 13.2.1.5. Thailand
      • 13.2.1.6. Indonesia
      • 13.2.1.7. Australia
      • 13.2.1.8. New Zealand
      • 13.2.1.9. Rest of Asia Pacific
    • 13.2.2. By Product
    • 13.2.3. By Type
    • 13.2.4. By Age Group
    • 13.2.5. By End User
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Type
    • 13.3.4. By Age Group
    • 13.3.5. By End User
  • 13.4. Key Takeaways

14. MEA Hydrocephalus Shunts Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. GCC Countries
      • 14.2.1.2. South Africa
      • 14.2.1.3. Israel
      • 14.2.1.4. Rest of MEA
    • 14.2.2. By Product
    • 14.2.3. By Type
    • 14.2.4. By Age Group
    • 14.2.5. By End User
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Type
    • 14.3.4. By Age Group
    • 14.3.5. By End User
  • 14.4. Key Takeaways

15. Key Countries Hydrocephalus Shunts Market Analysis

  • 15.1. U.S.
    • 15.1.1. Pricing Analysis
    • 15.1.2. Market Share Analysis, 2024
      • 15.1.2.1. By Product
      • 15.1.2.2. By Type
      • 15.1.2.3. By Age Group
      • 15.1.2.4. By End User
  • 15.2. Canada
    • 15.2.1. Pricing Analysis
    • 15.2.2. Market Share Analysis, 2024
      • 15.2.2.1. By Product
      • 15.2.2.2. By Type
      • 15.2.2.3. By Age Group
      • 15.2.2.4. By End User
  • 15.3. Brazil
    • 15.3.1. Pricing Analysis
    • 15.3.2. Market Share Analysis, 2024
      • 15.3.2.1. By Product
      • 15.3.2.2. By Type
      • 15.3.2.3. By Age Group
      • 15.3.2.4. By End User
  • 15.4. Mexico
    • 15.4.1. Pricing Analysis
    • 15.4.2. Market Share Analysis, 2024
      • 15.4.2.1. By Product
      • 15.4.2.2. By Type
      • 15.4.2.3. By Age Group
      • 15.4.2.4. By End User
  • 15.5. Germany
    • 15.5.1. Pricing Analysis
    • 15.5.2. Market Share Analysis, 2024
      • 15.5.2.1. By Product
      • 15.5.2.2. By Type
      • 15.5.2.3. By Age Group
      • 15.5.2.4. By End User
  • 15.6. U.K.
    • 15.6.1. Pricing Analysis
    • 15.6.2. Market Share Analysis, 2024
      • 15.6.2.1. By Product
      • 15.6.2.2. By Type
      • 15.6.2.3. By Age Group
      • 15.6.2.4. By End User
  • 15.7. France
    • 15.7.1. Pricing Analysis
    • 15.7.2. Market Share Analysis, 2024
      • 15.7.2.1. By Product
      • 15.7.2.2. By Type
      • 15.7.2.3. By Age Group
      • 15.7.2.4. By End User
  • 15.8. Spain
    • 15.8.1. Pricing Analysis
    • 15.8.2. Market Share Analysis, 2024
      • 15.8.2.1. By Product
      • 15.8.2.2. By Type
      • 15.8.2.3. By Age Group
      • 15.8.2.4. By End User
  • 15.9. Italy
    • 15.9.1. Pricing Analysis
    • 15.9.2. Market Share Analysis, 2024
      • 15.9.2.1. By Product
      • 15.9.2.2. By Type
      • 15.9.2.3. By Age Group
      • 15.9.2.4. By End User
  • 15.10. China
    • 15.10.1. Pricing Analysis
    • 15.10.2. Market Share Analysis, 2024
      • 15.10.2.1. By Product
      • 15.10.2.2. By Type
      • 15.10.2.3. By Age Group
      • 15.10.2.4. By End User
  • 15.11. Japan
    • 15.11.1. Pricing Analysis
    • 15.11.2. Market Share Analysis, 2024
      • 15.11.2.1. By Product
      • 15.11.2.2. By Type
      • 15.11.2.3. By Age Group
      • 15.11.2.4. By End User
  • 15.12. South Korea
    • 15.12.1. Pricing Analysis
    • 15.12.2. Market Share Analysis, 2024
      • 15.12.2.1. By Product
      • 15.12.2.2. By Type
      • 15.12.2.3. By Age Group
      • 15.12.2.4. By End User
  • 15.13. Singapore
    • 15.13.1. Pricing Analysis
    • 15.13.2. Market Share Analysis, 2024
      • 15.13.2.1. By Product
      • 15.13.2.2. By Type
      • 15.13.2.3. By Age Group
      • 15.13.2.4. By End User
  • 15.14. Thailand
    • 15.14.1. Pricing Analysis
    • 15.14.2. Market Share Analysis, 2024
      • 15.14.2.1. By Product
      • 15.14.2.2. By Type
      • 15.14.2.3. By Age Group
      • 15.14.2.4. By End User
  • 15.15. Indonesia
    • 15.15.1. Pricing Analysis
    • 15.15.2. Market Share Analysis, 2024
      • 15.15.2.1. By Product
      • 15.15.2.2. By Type
      • 15.15.2.3. By Age Group
      • 15.15.2.4. By End User
  • 15.16. Australia
    • 15.16.1. Pricing Analysis
    • 15.16.2. Market Share Analysis, 2024
      • 15.16.2.1. By Product
      • 15.16.2.2. By Type
      • 15.16.2.3. By Age Group
      • 15.16.2.4. By End User
  • 15.17. New Zealand
    • 15.17.1. Pricing Analysis
    • 15.17.2. Market Share Analysis, 2024
      • 15.17.2.1. By Product
      • 15.17.2.2. By Type
      • 15.17.2.3. By Age Group
      • 15.17.2.4. By End User
  • 15.18. GCC Countries
    • 15.18.1. Pricing Analysis
    • 15.18.2. Market Share Analysis, 2024
      • 15.18.2.1. By Product
      • 15.18.2.2. By Type
      • 15.18.2.3. By Age Group
      • 15.18.2.4. By End User
  • 15.19. South Africa
    • 15.19.1. Pricing Analysis
    • 15.19.2. Market Share Analysis, 2024
      • 15.19.2.1. By Product
      • 15.19.2.2. By Type
      • 15.19.2.3. By Age Group
      • 15.19.2.4. By End User
  • 15.20. Israel
    • 15.20.1. Pricing Analysis
    • 15.20.2. Market Share Analysis, 2024
      • 15.20.2.1. By Product
      • 15.20.2.2. By Type
      • 15.20.2.3. By Age Group
      • 15.20.2.4. By End User

16. Market Structure Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Benchmarking
  • 16.3. Market Share Analysis of Top Players
    • 16.3.1. By Regional
    • 16.3.2. By Product
    • 16.3.3. By Type
    • 16.3.4. By Age Group
    • 16.3.5. By End User

17. Competition Analysis

  • 17.1. Competition Deep Dive
    • 17.1.1. B. Braun Melsungen AG
      • 17.1.1.1. Overview
      • 17.1.1.2. Product Portfolio
      • 17.1.1.3. Profitability by Market Segments
      • 17.1.1.4. Sales Footprint
      • 17.1.1.5. Strategy Overview
        • 17.1.1.5.1. Marketing Strategy
    • 17.1.2. Sophysa
      • 17.1.2.1. Overview
      • 17.1.2.2. Product Portfolio
      • 17.1.2.3. Profitability by Market Segments
      • 17.1.2.4. Sales Footprint
      • 17.1.2.5. Strategy Overview
        • 17.1.2.5.1. Marketing Strategy
    • 17.1.3. HpBio Proteses Inc.
      • 17.1.3.1. Overview
      • 17.1.3.2. Product Portfolio
      • 17.1.3.3. Profitability by Market Segments
      • 17.1.3.4. Sales Footprint
      • 17.1.3.5. Strategy Overview
        • 17.1.3.5.1. Marketing Strategy
    • 17.1.4. Integra LifeSciences Holdings Corporation
      • 17.1.4.1. Overview
      • 17.1.4.2. Product Portfolio
      • 17.1.4.3. Profitability by Market Segments
      • 17.1.4.4. Sales Footprint
      • 17.1.4.5. Strategy Overview
        • 17.1.4.5.1. Marketing Strategy
    • 17.1.5. KANEKA MEDIX CORPORATION
      • 17.1.5.1. Overview
      • 17.1.5.2. Product Portfolio
      • 17.1.5.3. Profitability by Market Segments
      • 17.1.5.4. Sales Footprint
      • 17.1.5.5. Strategy Overview
        • 17.1.5.5.1. Marketing Strategy
    • 17.1.6. Medtronic
      • 17.1.6.1. Overview
      • 17.1.6.2. Product Portfolio
      • 17.1.6.3. Profitability by Market Segments
      • 17.1.6.4. Sales Footprint
      • 17.1.6.5. Strategy Overview
        • 17.1.6.5.1. Marketing Strategy
    • 17.1.7. Natus Medical Incorporated
      • 17.1.7.1. Overview
      • 17.1.7.2. Product Portfolio
      • 17.1.7.3. Profitability by Market Segments
      • 17.1.7.4. Sales Footprint
      • 17.1.7.5. Strategy Overview
        • 17.1.7.5.1. Marketing Strategy
    • 17.1.8. Spiegelberg GmbH & Co. KG
      • 17.1.8.1. Overview
      • 17.1.8.2. Product Portfolio
      • 17.1.8.3. Profitability by Market Segments
      • 17.1.8.4. Sales Footprint
      • 17.1.8.5. Strategy Overview
        • 17.1.8.5.1. Marketing Strategy
    • 17.1.9. Desu Medical
      • 17.1.9.1. Overview
      • 17.1.9.2. Product Portfolio
      • 17.1.9.3. Profitability by Market Segments
      • 17.1.9.4. Sales Footprint
      • 17.1.9.5. Strategy Overview
        • 17.1.9.5.1. Marketing Strategy
    • 17.1.10. Natus Neuro
      • 17.1.10.1. Overview
      • 17.1.10.2. Product Portfolio
      • 17.1.10.3. Profitability by Market Segments
      • 17.1.10.4. Sales Footprint
      • 17.1.10.5. Strategy Overview
        • 17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology